The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

(2018) Jing Wang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

(2017) Catherine J Lee et al.   HAEMATOLOGICA

Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis

(2017) Ying-Jun Chang et al.   Journal of Hematology & Oncology

Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

(2017) Lan-Ping Xu et al.   Journal of Hematology & Oncology

Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants

(2017) Y Wang et al.   LEUKEMIA

Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era

(2017) Huan Chen et al.   LEUKEMIA RESEARCH

Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

(2017) Catherine J Lee et al.   HAEMATOLOGICA

The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor, or haploidentical family donor in patients with leukemia: a retrospective analysis of data from the China RIC Cooperative Group

(2016) Chang-Lin Yu et al.   ANNALS OF HEMATOLOGY

Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia

(2016) Lan-Ping Xu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update

(2016) W-R Huang et al.   BONE MARROW TRANSPLANTATION

Long-term outcomes of HLA-haploidentical stem cell transplantation based on an FBCA conditioning regimen compared with those of HLA-identical sibling stem cell transplantation for haematologic malignancies

(2016) H Long et al.   BONE MARROW TRANSPLANTATION

Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia

(2016) L P Xu et al.   BONE MARROW TRANSPLANTATION

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

(2016) D Niederwieser et al.   BONE MARROW TRANSPLANTATION

Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study

(2016) Lan-Ping Xu et al.   BRITISH JOURNAL OF HAEMATOLOGY

Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study

(2016) Y. Wang et al.   CLINICAL CANCER RESEARCH

Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis

(2016) Yan-Ru Ma et al.   CLINICAL TRANSPLANTATION

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database

(2016) Y. Sun et al.   HAEMATOLOGICA

Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia

(2016) Xiao-Dong Mo et al.   INTERNATIONAL JOURNAL OF CANCER

Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia

(2016) Zhi Guo et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

(2016) Marie T. Rubio et al.   Journal of Hematology & Oncology

How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

(2016) Ying-Jun Chang et al.   Journal of Hematology & Oncology

Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant

(2016) Y Wang et al.   LEUKEMIA

Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantation

(2016) Ying-Jun Chang et al.   LEUKEMIA & LYMPHOMA

Haploidentical hematopoietic stem cell transplantation for paediatric high-risk T-cell acute lymphoblastic leukaemia

(2016) Zheng-Li Xu et al.   PEDIATRIC TRANSPLANTATION

Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study

(2016) Xiangyu Zhao et al.   Science China-Life Sciences

Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT

(2016) Li Xuan et al.   Oncotarget

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database

(2016) Y. Sun et al.   HAEMATOLOGICA

Haploidentical Hematopoietic Stem Cell Transplantation without In Vitro T Cell Depletion for the Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

(2015) Huan Chen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

(2015) Navneet S. Majhail et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

(2015) Yu Wang et al.   BLOOD

A retrospective comparison of BU-fludarabine and BU–CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT

(2015) Y-q Sun et al.   BONE MARROW TRANSPLANTATION

Haploidentical stem cell transplantation in patients aged 50 yr and older with leukemia: similar outcomes compared to younger adults

(2015) Yao Chen et al.   CLINICAL TRANSPLANTATION

Recipient expression of ligands for donor inhibitory KIRs enhances NK-cell function to control leukemic relapse after haploidentical transplantation

(2015) Xiang-Yu Zhao et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets

(2015) Ying-Jun Chang et al.   Journal of Hematology & Oncology

Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China

(2015) Li Gao et al.   Journal of Hematology & Oncology

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy

(2015) Ya-Zhen Qin et al.   LEUKEMIA & LYMPHOMA

Pediatric hematopoietic stem cell transplantation in China: Data and trends during 1998-2012

(2015) Hong Du et al.   PEDIATRIC TRANSPLANTATION

Fighting against hematological malignancy in China: from unique system to global impact

(2015) Meng Lv et al.   Science China-Life Sciences

Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase

(2015) Lanping Xu et al.   Frontiers of Medicine

One million haemopoietic stem-cell transplants: a retrospective observational study

(2015) Alois Gratwohl et al.   Lancet Haematology

Effects of Priming with Recombinant Human Granulocyte Colony–Stimulating Factor on Conditioning Regimen for High-Risk Acute Myeloid Leukemia Patients Undergoing Human Leukocyte Antigen–Haploidentical Hematopoietic Stem Cell Transplantation: A Multicenter Randomized Controlled Study in Southwest China

(2014) Lei Gao et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Superior Survival of Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Compared with Chemotherapy Alone Used as Post-Remission Therapy in Adults with Standard-Risk Acute Lymphoblastic Leukemia in First Complete Remission

(2014) Chen-Hua Yan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

(2014) Y. Luo et al.   BLOOD

Who is the best donor for a related HLA haplotype-mismatched transplant?

(2014) Y. Wang et al.   BLOOD

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis

(2014) H Jiang et al.   BONE MARROW TRANSPLANTATION

EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation

(2014) H-t Wang et al.   BONE MARROW TRANSPLANTATION

Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy

(2014) L Gao et al.   BONE MARROW TRANSPLANTATION

Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL

(2014) Y-q Sun et al.   BONE MARROW TRANSPLANTATION

HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients

(2014) X-Y Zhao et al.   BRITISH JOURNAL OF CANCER

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome–positive or BCR-ABL–positive acute lymphoblastic leukemia: a Canadian consensus

(2014) S. Couban et al.   Current Oncology

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry

(2014) Loren Gragert et al.   NEW ENGLAND JOURNAL OF MEDICINE

The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation

(2013) Xiao-Dong Mo et al.   AMERICAN JOURNAL OF HEMATOLOGY

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

(2013) H.-H. Zhu et al.   BLOOD

Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia

(2013) D-H Liu et al.   BONE MARROW TRANSPLANTATION

Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia

(2013) Q Jiang et al.   LEUKEMIA

Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome

(2013) Li Gao et al.   LEUKEMIA RESEARCH

Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens

(2012) Qi-Fa Liu et al.   ANNALS OF HEMATOLOGY

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission

(2012) X.-J. Huang et al.   BLOOD

A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia

(2012) L P Xu et al.   BONE MARROW TRANSPLANTATION

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia

(2012) Yu Wang et al.   CANCER

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go

(2012) Meng Lv et al.   Journal of Hematology & Oncology

Haploidentical/Mismatched Hematopoietic Stem Cell Transplantation without In Vitro T Cell Depletion for T Cell Acute Lymphoblastic Leukemia

(2011) Yu Wang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase

(2011) Q. Jiang et al.   BLOOD

Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia

(2011) Yi Luo et al.   LEUKEMIA RESEARCH

Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Hematopoietic Stem Cell Transplantation

(2010) Xiao-Jun Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome

(2010) Y Chen et al.   BONE MARROW TRANSPLANTATION

Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies

(2010) Xing-Hua Chen et al.   TRANSFUSION AND APHERESIS SCIENCE

Haploidentical Hematopoietic Stem Cell Transplantation without In Vitro T Cell Depletion for Treatment of Hematologic Malignancies in Children

(2009) Xiaojun Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation

(2009) Xiao-Jun Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Sequential Intensified Conditioning and Tapering of Prophylactic Immunosuppressants for Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Leukemia

(2009) Qi-Fa Liu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome

(2009) Yvette L. Kasamon et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable with Unrelated Donor Transplantation for Patients with Hematologic Malignancies

(2009) H. Xiao-Jun et al.   CLINICAL CANCER RESEARCH